Diversified Enterprises’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Diversified Enterprises’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$485K	Hold	2,417	–	–	0.03%	245
2025 Q4	$499K	Hold	2,417	–	–	0.03%	216
2025 Q3	$433K	Hold	2,417	–	–	0.03%	179
2025 Q2	$390K	Hold	2,417	–	–	0.03%	190
2025 Q1	$411K	Hold	2,417	–	–	0.03%	180
2024 Q4	$402K	Buy	2,417 +7	+0.3%	+$1.2K	0.04%	154
2024 Q3	$414K	Buy	+2,410	New	+$399K	0.05%	140

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Diversified Enterprises's FBT Position: Q1 2026 in Review

Diversified Enterprises held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 2,417 shares worth $485K. The position accounts for 0.03% of the portfolio, ranked #245.

Diversified Enterprises first reported a position in FBT in Q3 2024 and has held it in 7 quarters since. The position peaked at $499K in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Diversified Enterprises held 2,417 shares of First Trust NYSE Arca Biotechnology Index Fund worth $485K as of Q1 2026.
Diversified Enterprises left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Diversified Enterprises's portfolio in Q1 2026, its #245 holding.
Diversified Enterprises first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2024 and has held it in 7 quarters since.
Diversified Enterprises's First Trust NYSE Arca Biotechnology Index Fund position peaked at $499K in Q4 2025.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Diversified Enterprises's 13F filing for Q1 2026, filed 15 May 2026.